Volume 63, Issue 3, Pages (March 2003)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

A.M. Thompson, T.G. Pickering  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
Kamyar Kalantar-Zadeh, Connie M. Rhee, Jason Chou, S
Nutrition and chronic kidney disease
Body Mass Index and All-cause Mortality in Chronic Kidney Disease: A Dose–response Meta-analysis of Observational Studies  Mehran Rahimlu, MSc, Sakineh.
by Kamyar Kalantar-Zadeh, Ryan D. Kilpatrick, Charles J
Iron indices: What do they really mean?
Volume 69, Issue 11, Pages (June 2006)
Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Volume 70, Issue 8, Pages (October 2006)
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Association of Relatively Low Serum Parathyroid Hormone With Malnutrition- Inflammation Complex and Survival in Maintenance Hemodialysis Patients  Ramanath.
Volume 78, Pages S10-S21 (August 2010)
Determinants of phosphorus mobilization during hemodialysis
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.
Volume 86, Issue 4, Pages (October 2014)
Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients?  David E. St-Jules, RD, PhD,
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Kamyar Kalantar-Zadeh  Kidney International 
Volume 76, Pages S50-S99 (August 2009)
Let Them Eat During Dialysis: An Overlooked Opportunity to Improve Outcomes in Maintenance Hemodialysis Patients  Kamyar Kalantar-Zadeh, MD, MPH, PhD,
Homocysteine and risk in end-stage renal disease: a matter of context
Volume 68, Issue 6, Pages (December 2005)
Volume 68, Issue 4, Pages (October 2005)
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients  Tatsuya Shoji, Yoshiharu Tsubakihara,
Volume 56, Issue 2, Pages (August 1999)
Nutrition and chronic kidney disease
Survival advantage in Asian American end-stage renal disease patients1
Volume 77, Issue 7, Pages (April 2010)
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia  Blair S. Grace, Philip A. Clayton, Alan.
Volume 65, Issue 2, Pages (February 2004)
Volume 80, Issue 2, Pages (July 2011)
Donna L. Mapes, DNSc, Jennifer L
Volume 62, Issue 6, Pages (December 2002)
Gentamicin pharmacokinetics during slow daily home hemodialysis
Study of Heart and Renal Protection (SHARP)
Body size and outcomes on peritoneal dialysis in the United States
Volume 54, Issue 2, Pages (August 1998)
Anemia as a risk factor for cardiovascular disease
Blood pressure targets in hemodialysis patients
Volume 67, Pages S63-S68 (January 2005)
Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra 
Cardiac arrest and sudden death in dialysis units
Volume 70, Issue 10, Pages (November 2006)
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Alternate-day dialysis may be needed for hemodialysis patients
Volume 71, Issue 6, Pages (March 2007)
Volume 61, Issue 1, Pages (January 2002)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 56, Issue 5, Pages (November 1999)
Volume 58, Issue 1, Pages (July 2000)
Volume 64, Issue 2, Pages (August 2003)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
The Danish Renal Biopsy Register
Volume 60, Issue 3, Pages (September 2001)
Clinical and biochemical correlates of starting “daily” hemodialysis
Volume 60, Issue 6, Pages (December 2001)
Importance of blood pressure control in hemodialysis patient survival
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
Volume 61, Issue 2, Pages (February 2002)
Volume 76, Issue 5, Pages (September 2009)
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Volume 69, Issue 7, Pages (April 2006)
Mortality predictability of the difference of the percentiles of the changes in dietary protein intake, represented by nPNA (nPCR), and serum P concentration.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Volume 63, Issue 3, Pages 793-808 (March 2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients  Kamyar Kalantar-Zadeh, Gladys Block, Michael H. Humphreys, Joel D. Kopple  Kidney International  Volume 63, Issue 3, Pages 793-808 (March 2003) DOI: 10.1046/j.1523-1755.2003.00803.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Reverse epidemiology of mortality risk factors in maintenance dialysis patients. Comparison between the impacts of body mass index (BMI) on all-cause mortality in the general population versus the maintenance hemodialysis population. The general population data are adopted from Calle et al, N Engl J Med 341:1097-1105, 1991 (combined men and women, healthy, nonsmoker)136. The hemodialysis data are adopted from Leavey et al, Nephrol Dial Transplant 16:2386-2394, 2001 (combined data from the United States and Europe)26. *Each population has a different follow-up period: 14 years for the general population versus 4 years for hemodialysis patients. **BMI stratifications are different in two populations: X-axis is based on the original graph of the general population and the original hemodialysis BMI subgroup ranges are printed additionally along the hemodialysis curve. Kidney International 2003 63, 793-808DOI: (10.1046/j.1523-1755.2003.00803.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Relative mortality risk versus body mass index (BMI) in hemodialysis patients: United States and Europe (DOPPS Study). (A) Mortality risk decreases as BMI increases. An inverse linear relationship between mortality and ln (BMI) is significant for both the United States and Europe (P < 0.0001). Adjusted for demographics, all comorbid conditions and albumin. (B) Relative mortality risk versus BMI for sicker and healthier hemodialysis patients. Tertiles of a linear indicator of severity of illness define the three cohorts. In each cohort mortality risk was highest for BMI < 20 and lowest for BMI> or = 30 (Inverse linear relationship with lane (BMI), P < 0.0001). Reprinted with permission from Leavey et al, Nephrol Dial Transplant 16:2386–2394, 200126. Reprinted with permission from Leavey et al, Nephrol Dial Transplant 16:2386–2394, 200126. Kidney International 2003 63, 793-808DOI: (10.1046/j.1523-1755.2003.00803.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Relative risk (RR) of death according to predialysis systolic blood pressure compared with the reference group of 120 to 149 mm Hg (RR = 1.00). Three separate models are shown according to the level of statistical adjustment. *P < 0.0001. Reprinted with permission from Port FK et al, Am J Kidney Dis 3:507–517, 199951. Kidney International 2003 63, 793-808DOI: (10.1046/j.1523-1755.2003.00803.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Relative risk (RR) of death in hemodialysis patients according to serum cholesterol concentration compared to the reference group (cholesterol 200 to 250 mg/dL, RR=1.00). Reprinted with permission from Lowrie EG and Lew NL, Am J Kidney Dis 15:458-482, 19905. Kidney International 2003 63, 793-808DOI: (10.1046/j.1523-1755.2003.00803.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 A hypothetical representation of combining two competing risk factors with time discrepancy. (A) A low serum cholesterol in the setting of under-nutrition is a short-term marker of mortality (1-year scale). (B) A high serum cholesterol in the setting of over-nutrition leads to an increased mortality rate over a long-term interval (10-year scale). (C) After combing both impacts, the short-term risk factor pattern (under-nutrition associated hypocholesterolemia) predominates. Kidney International 2003 63, 793-808DOI: (10.1046/j.1523-1755.2003.00803.x) Copyright © 2003 International Society of Nephrology Terms and Conditions